Videa Perio Assist
VideaHealth, Inc. • Radiology • 02/06/2023
Device Purpose
Videa Perio Assist is an AI-powered, cloud-based software designed to assist dental professionals by semi-automating the measurement and visualization of interproximal alveolar bone levels from bitewing and periapical radiographs. The system employs image processing algorithms to identify dental landmarks and calculate bone levels, presented as linear distances or percentages, to support clinical assessment of periodontal health in patients with permanent dentition.
Summary
Videa Perio Assist is a radiological semi-automated image processing software developed to aid dental professionals, including dentists and dental hygienists, in evaluating periodontal health. Its primary purpose is to measure and visualize mesial and distal alveolar bone levels associated with each tooth, utilizing bitewing and periapical radiographs from patients aged 12 and older with permanent dentition. The system operates as a cloud-based, AI-powered API that integrates with existing image viewers, allowing users to upload radiographs and receive outputs displaying identified bone levels as linear distances in millimeters or as percentages of root length. It is designed as an assistive tool and should not replace comprehensive patient evaluation or be the sole basis for diagnosis. The device's performance was evaluated through non-clinical bench testing and clinical studies. Bench testing on 996 radiographs demonstrated high recall (94.4% bitewing, 91.9% periapical) and precision (84.3% bitewing), though periapical precision was lower (79.1%) in subgroups with obscured interproximal points due to tooth overlap. Clinical testing on 189 radiographs, with results compared against a reference standard set by periodontists, showed good sensitivity (92.8% bitewing, 88.3% periapical) and specificity (89.4% bitewing, 87.0% periapical), with mean absolute error meeting pre-specified criteria (less than 1.5mm). While generally robust across different sensor manufacturers and patient age groups, some specific subgroups, such as periapical CEJ-ABL measurements for specificity and certain sensor/age combinations for specificity on bitewings, showed performance below acceptance criteria, often attributed to challenges like tooth overlap, though these instances were not deemed to impact overall millimeter accuracy when a prediction was made.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the Videa Perio Assist algorithm differentiate between true alveolar bone loss and anatomical variations or radiographic artifacts, particularly in the periapical CEJ-ABL subgroup where specificity was lower?; What specific image quality parameters (e.g., contrast, resolution, angulation) are most critical for the optimal performance of Videa Perio Assist, and how does the system address or flag suboptimal images?; Beyond the three sensor manufacturers tested, how robust is the device's performance across a wider range of intraoral X-ray sensors and imaging systems commonly found in diverse dental practices?; Could the AI be enhanced to provide a confidence score for its measurements, especially in challenging cases with overlapping teeth or obscured landmarks, to better guide clinical interpretation?; What is the typical learning curve for dental professionals to effectively integrate Videa Perio Assist into their daily workflow and accurately interpret its outputs, particularly when the software's measurements might differ from initial visual assessments?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly